Description

About the Author

Dr. Mrinal Kanti Guha is a renowned diabetologist with numerous years of consulting experience and expertise.

Dr. Guha has pursued training from premier institutes like CMC Vellore and San Rafael Hospital (Milan, Italy) and also completed a postgraduate diploma in clinical endocrinology and diabetes from the Royal College of Physicians (UK). Dr. Guha also holds a fellowship in diabetes management from Martin Luther University. Dr. Guha has a keen interest in research and has published numerous original research papers in various national and international Journals. Under his leadership, several CMEs and training programmes on different aspects of diabetes have been conducted for general practitioners, physicians, and medical students. Dr. Guha is a regularly invited speaker at several national and international conferences

About the Book

The increasing prevalence of diabetes makes it imperative that research focus on its prevention as well as its treatment. Epidemiologic studies have established an association between inflammatory biomarkers and the occurrence of T2DM and its complications. An improved understanding of the mechanisms linking inflammation to diabetes and related complications has stimulated interest in targeting inflammatory pathways as part of the strategy to prevent or control diabetes and its complications. This book will highlight the emerging role of inflammation in the pathophysiology of diabetes, and we will analyse the implicated inflammatory pathways and biomarkers of inflammation in diabetes and metabolic diseases. The focus of this book is to provide an overview of the current state of knowledge on anti-inflammatory theraples for diabetes, along with perspectives on future therapies for the disease.